1. Home
  2. CRCT vs COLL Comparison

CRCT vs COLL Comparison

Compare CRCT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRCT
  • COLL
  • Stock Information
  • Founded
  • CRCT 1969
  • COLL 2002
  • Country
  • CRCT United States
  • COLL United States
  • Employees
  • CRCT N/A
  • COLL N/A
  • Industry
  • CRCT Wholesale Distributors
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRCT Industrials
  • COLL Health Care
  • Exchange
  • CRCT Nasdaq
  • COLL Nasdaq
  • Market Cap
  • CRCT 1.4B
  • COLL 958.8M
  • IPO Year
  • CRCT 2021
  • COLL 2015
  • Fundamental
  • Price
  • CRCT $5.30
  • COLL $32.52
  • Analyst Decision
  • CRCT Sell
  • COLL Strong Buy
  • Analyst Count
  • CRCT 3
  • COLL 4
  • Target Price
  • CRCT $4.52
  • COLL $43.75
  • AVG Volume (30 Days)
  • CRCT 661.9K
  • COLL 304.4K
  • Earning Date
  • CRCT 08-05-2025
  • COLL 08-07-2025
  • Dividend Yield
  • CRCT 16.87%
  • COLL N/A
  • EPS Growth
  • CRCT 6.92
  • COLL N/A
  • EPS
  • CRCT 0.31
  • COLL 1.25
  • Revenue
  • CRCT $707,780,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • CRCT N/A
  • COLL $20.04
  • Revenue Next Year
  • CRCT $1.18
  • COLL $3.98
  • P/E Ratio
  • CRCT $18.18
  • COLL $25.91
  • Revenue Growth
  • CRCT N/A
  • COLL 17.17
  • 52 Week Low
  • CRCT $3.94
  • COLL $23.23
  • 52 Week High
  • CRCT $7.33
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • CRCT 31.14
  • COLL 69.85
  • Support Level
  • CRCT $5.80
  • COLL $30.60
  • Resistance Level
  • CRCT $7.33
  • COLL $33.22
  • Average True Range (ATR)
  • CRCT 0.26
  • COLL 0.85
  • MACD
  • CRCT -0.18
  • COLL 0.27
  • Stochastic Oscillator
  • CRCT 0.49
  • COLL 82.32

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: